Oophorectomy-induced bone loss is attenuated in MAGP1-deficient mice

Journal of Cellular Biochemistry

Volumn 113, Issue 1, 2012, Pages 93-99

  Craft, Clarissa S ^a   Broekelmann, Thomas J ^a   Zou, Wei ^a   Chappel, Jean C ^a   Teitelbaum, Steven L ^a   Mecham, Robert P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone; MAGP1; Microfibril; Oophorectomy; Rankl

Indexed keywords

GLYCOPROTEIN; MICROFIBRIL ASSOCIATED GLYCOPROTEIN 1; NEUTRALIZING ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; CELL DIFFERENTIATION; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; RAT;

ANIMALS; BONE DISEASES, METABOLIC; BONE RESORPTION; CELL DIFFERENTIATION; CELLS, CULTURED; CONTRACTILE PROTEINS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; MICE; MICE, KNOCKOUT; MICROFIBRILS; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; OVARIECTOMY; RANK LIGAND; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84055218468     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23331     Document Type: Article

References (30)

1. Arteage-Solis E, Ramirez F,. 2008. Marfan syndrome and related disorders of the connective tissue. In:, Rosen CJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. Washington, DC: American Society for Bone and Mineral Research. pp 450-454.
2. Barisic-Dujmovic T, Boban I, Adams DJ, Clark SH,. 2007. Marfan-like skeletal phenotype in the tight skin (Tsk) mouse. Calcif Tissue Int 81: 305-315. (Pubitemid 47498102)
3. Boyce BF, Xing L,. 2007. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther 9 (Suppl 1): S1.
4. Cleary EG, Gibson MA,. 1983. Elastin-associated microfibrils and microfibrillar proteins. Int Rev Connect Tissue Res 10: 97-209. (Pubitemid 14241709)
5. Craft CS, Zou W, Watkins M, Grimston SK, Brodt MD, Broekelmann TJ, Weinbaum JS, Teitelbaum SL, Civitelli R, Silva MJ, Mecham RP,. 2010. Microfibril-associated glycoprotein-1 (MAGP1), an extracellular matrix regulator of bone remodeling. J Biol Chem 283 (37): 25533-25543.
6. Dallas SL, Keene DR, Bruder SP, Saharinen J, Sakai LY, Mundy GR, Bonewald LF,. 2000. Role of the latent transforming growth factor beta binding protein 1 in fibrillin-containing microfibrils in bone cells in vitro and in vivo. J Bone Miner Res 15: 68-81. (Pubitemid 30026934)
7. Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL,. 2003. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111: 1221-1230. (Pubitemid 36519939)
8. Gregory KE, Ono RN, Charbonneau NL, Kuo CL, Keene DR, Bachinger HP, Sakai LY,. 2005. The prodomain of BMP-7 targets the BMP-7 complex to the extracellular matrix. J Biol Chem 280: 27970-27980. (Pubitemid 41076914)
9. Hofbauer LC, Schoppet M,. 2004. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 292: 490-495. (Pubitemid 38988958)
10. Katagiri T, Takahashi N,. 2002. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 8: 147-159. (Pubitemid 34535063)
11. Lai CF, Cheng SL, Mbalaviele G, Donsante C, Watkins M, Radice GL, Civitelli R,. 2006. Accentuated ovariectomy-induced bone loss and altered osteogenesis in heterozygous N-cadherin null mice. J Bone Miner Res 21: 1897-1906. (Pubitemid 44851566)
12. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL,. 2000. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106: 1481-1488. (Pubitemid 32038586)
13. Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, Xu FL, Myers LA, Spevak PJ, Cameron DE, De Backer J, Hellemans J, Chen Y, Davis EC, Webb CL, Kress W, Coucke P, Rifkin DB, De Paepe AM, Dietz HC,. 2005. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37: 275-281. (Pubitemid 41716254)
14. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S, Roberts AE, Faravelli F, Greco MA, Pyeritz RE, Milewicz DM, Coucke PJ, Cameron DE, Braverman AC, Byers PH, De Paepe AM, Dietz HC,. 2006. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 355: 788-798. (Pubitemid 44285584)
15. Massam-Wu T, Chiu M, Choudhury R, Chaudhry SS, Baldwin AK, McGovern A, Baldock C, Shuttleworth CA, Kielty CM,. 2010. Assembly of fibrillin microfibrils governs extracellular deposition of latent TGF beta. J Cell Sci 123: 3006-3018.
16. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, Ramirez F, Sakai LY, Dietz HC,. 2003. Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33: 407-411. (Pubitemid 36278859)
17. Nistala H, Lee-Arteaga S, Carta L, Cook JR, Smaldone S, Siciliano G, Rifkin AN, Dietz HC, Rifkin DB, Ramirez F,. 2010a. Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome. Hum Mol Genet 19: 4790-4798.
18. Nistala H, Lee-Arteaga S, Smaldone S, Siciliano G, Ramirez F,. 2010b. Extracellular microfibrils control osteoblast-supported osteoclastogenesis by restricting TGF{beta} stimulation of RANKL production. J Biol Chem 285: 34126-34133.
19. Nistala H, Lee-Arteaga S, Smaldone S, Siciliano G, Carta L, Ono RN, Sengle G, Arteaga-Solis E, Levasseur R, Ducy P, Sakai LY, Karsenty G, Ramirez F,. 2010c. Fibrillin-1 and -2 differentially modulate endogenous TGF-beta and BMP bioavailability during bone formation. J Cell Biol 190: 1107-1121.
20. Ominsky MS, Li X, Asuncion FJ, Barrero M, Warmington KS, Dwyer D, Stolina M, Geng Z, Grisanti M, Tan HL, Corbin T, McCabe J, Simonet WS, Ke HZ, Kostenuik PJ,. 2008. RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats. J Bone Miner Res 23: 672-682. (Pubitemid 351575021)
21. Pereira L, Lee SY, Gayraud B, Andrikopoulos K, Shapiro SD, Bunton T, Biery NJ, Dietz HC, Sakai LY, Ramirez F,. 1999. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci USA 96: 3819-3823. (Pubitemid 29168994)
22. Ramirez F, Dietz HC,. 2009. Extracellular microfibrils in vertebrate development and disease processes. J Biol Chem 284: 14677-14681.
23. Ramirez F, Carta L, Lee-Arteaga S, Liu C, Nistala H, Smaldone S,. 2008. Fibrillin-rich microfibrils-Structural and instructive determinants of mammalian development and physiology. Connect Tissue Res 49: 1-6. (Pubitemid 351298148)
24. Rodan GA, Martin TJ,. 2000. Therapeutic approaches to bone diseases. Science 289: 1508-1514.
25. Sakai LY, Keene DR, Engvall E,. 1986. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol 103: 2499-2509. (Pubitemid 17216674)
26. Samadfam R, Xia Q, Goltzman D,. 2007. Co-treatment of PTH with osteoprotegerin or alendronate increases its anabolic effect on the skeleton of oophorectomized mice. J Bone Miner Res 22: 55-63. (Pubitemid 46032597)
27. Segade F, Suganuma N, Mychaleckhj JC, Mecham RP,. 2007. The intracellular form of human MAGP1 elicits a complex and specific transcriptional response. Int J Biochem Cell Biol 39: 2303-2313. (Pubitemid 47484284)
28. Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S,. 2000. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 43: 259-269. (Pubitemid 30395733)
29. Weinbaum JS, Broekelmann TJ, Pierce RA, Werneck CC, Segade F, Craft CS, Knutsen RH, Mecham RP,. 2008. Deficiency in microfibril-associated glycoprotein-1 leads to complex phenotypes in multiple organ systems. J Biol Chem 283: 25533-25543.
30. Werneck CC, Vicente CP, Weinberg JS, Shifren A, Pierce RA, Broekelmann TJ, Tollefsen DM, Mecham RP,. 2008. Mice lacking the extracellular matrix protein MAGP1 display delayed thrombotic occlusion following vessel injury. Blood 111: 4137-4144.